SARS-CoV-2 antibody testing for estimating COVID-19 prevalence in the population

Cell Rep Med. 2021 Feb 16;2(2):100191. doi: 10.1016/j.xcrm.2021.100191. Epub 2021 Jan 14.

Abstract

Reliable antibody testing against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has the potential to uncover the population-wide spread of coronavirus disease 2019 (COVID-19), which is critical for making informed healthcare and economic decisions. Here we review different types of antibody tests available for SARS-CoV-2 and their application for population-scale testing. Biases because of varying test accuracy, results of ongoing large-scale serological studies, and use of antibody testing for monitoring development of herd immunity are summarized. Although current SARS-CoV-2 antibody testing efforts have generated valuable insights, the accuracy of serological tests and the selection criteria for the tested cohorts need to be evaluated carefully.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Antibodies, Viral / blood*
  • Antibodies, Viral / immunology
  • COVID-19 / diagnosis*
  • COVID-19 / epidemiology
  • COVID-19 / virology
  • Humans
  • Immunity, Herd
  • Immunoassay
  • Prevalence
  • SARS-CoV-2 / immunology
  • SARS-CoV-2 / isolation & purification
  • SARS-CoV-2 / metabolism
  • Sensitivity and Specificity
  • Serologic Tests / methods*

Substances

  • Antibodies, Viral